6 recruiting, 3 completed, 1 active not recruiting, 1 no longer available. 2 Early Phase 1, 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Multiple System Atrophy (MSA): new trials by email Literature Review of Multiple System Atrophy (MSA) trials Research Report on Multiple System Atrophy (MSA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA SST001 - Multiple System Atrophy (MSA), Parkinson's Disease (PD) | Phase 1 | Recruiting | Synusight Biotech (Shanghai) Co., Ltd. | 30 | 2026-06-15 | 2026-09-01 |
| Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies [¹⁸F]MODAG-009 PET imaging - Multiple System Atrophy (MSA), Healthy Adult | Early Phase 1 | Recruiting | MODAG GmbH | 13 | 2026-05-13 | 2026-06-10 |
| MSA-01 in Multiple System Atrophy MSA-01, Placebo - Multiple System Atrophy (MSA) | Phase 3 | Recruiting | Tokyo University | 140 | 2026-02-09 | 2026-03-04 |
| [18F]ACI-15916 PET in α-synucleinopathies [18F]ACI-15916 - Parkinson's Disease (PD), Multiple System Atrophy (MSA) | Early Phase 1 | Recruiting | AC Immune SA | 46 | 2025-03-20 | 2026-10-28 |
| AI-Enhanced Optimization of Acute Levodopa Challenge Test video recording - Vascular Parkinsonism, Drug-induced Parkinsonism | Recruiting | Beijing Tiantan Hospital | 2000 | 2024-05-28 | 2025-04-29 | |
| A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy ONO-2808, Placebo - Multiple System Atrophy (MSA) | Phase 2 | Active not recruiting | Ono Pharmaceutical Co., Ltd. | 92 | 2023-09-22 | 2026-10-06 |
| A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD) | Phase 3 | Completed | GE Healthcare | 172 | 2020-06-28 | 2023-10-16 |
| Multiple System Atrophy Multidisciplinary Clinic Multiple System Atrophy (MSA) | Recruiting | University of Texas Southwestern Medical Center | 200 | 2016-03-01 | 2026-05-22 | |
| PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration | Unknown | University College, London | 900 | 2014-10-01 | 2020-10-19 | |
| Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI) Parkinson's Disease (PD), Parkinsonism | Completed | Milton S. Hershey Medical Center | 290 | 2012-12-01 | 2020-01-03 | |
| Oligomeric Alpha-synuclein in Multiple System Atrophy Multiple System Atrophy (MSA) | Completed | University Hospital, Bordeaux | 48 | 2012-11-26 | 2019-06-27 | |
| Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA) BHV3241, verdiperstat - Multiple System Atrophy (MSA) | No longer available | Biohaven Pharmaceuticals, Inc. | 2022-10-06 |
Multiple System Atrophy (12) · Parkinson Disease (6) · Supranuclear Palsy, Progressive (4) · Corticobasal Degeneration (2) · Parkinsonian Disorders (2) · Essential Tremor (1) · Lewy Body Disease (1) · Synucleinopathies (1)
Autonomic Nervous System Diseases (12) · Basal Ganglia Diseases (12) · Brain Diseases (12) · Central Nervous System Diseases (12) · Movement Disorders (12) · Nervous System Diseases (12) · Neurodegenerative Diseases (12) · Primary Dysautonomias (12) · Synucleinopathies (11) · Cranial Nerve Diseases (4) · Eye Diseases (4) · Neurologic Manifestations (4) · Ocular Motility Disorders (4) · Ophthalmoplegia (4) · Paralysis (4)
Injections (1) · Iodine-123 (1) · Videotape Recording (1) · ioflupane (1)
AC Immune SA (1) · Beijing Tiantan Hospital (1) · Biohaven Pharmaceuticals, Inc. (1) · GE Healthcare (1) · MODAG GmbH (1) · Milton S. Hershey Medical Center (1) · Ono Pharmaceutical Co., Ltd. (1) · Synusight Biotech (Shanghai) Co., Ltd. (1) · Tokyo University (1) · University College, London (1) · University Hospital, Bordeaux (1) · University of Texas Southwestern Medical Center (1)
United States (5) · China (3) · Japan (2) · France (1) · Sweden (1) · United Kingdom (1)
Andrea Varrone, Prof. (1) · Huw Morris, PhD, FRCP (1) · Project Leader (1) · Steven Vernino, M.D. (1)